Application 010040
- Type
- NDA
- Sponsor
- BRACCO
Application Products#
| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|---|---|---|---|---|---|
| 001 | RENOGRAFIN-76 | DIATRIZOATE MEGLUMINE; DIATRIZOATE SODIUM | INJECTABLE;INJECTION | 66%;10% | Yes | No |
| 006 | RENOGRAFIN-60 | DIATRIZOATE MEGLUMINE; DIATRIZOATE SODIUM | INJECTABLE;INJECTION | 52%;8% | No | No |
| 012 | RENO-DIP | DIATRIZOATE MEGLUMINE | INJECTABLE;INJECTION | 30% | No | No |
| 016 | RENO-60 | DIATRIZOATE MEGLUMINE | INJECTABLE;INJECTION | 60% | No | No |
| 017 | DIATRIZOATE MEGLUMINE | DIATRIZOATE MEGLUMINE | INJECTABLE;INJECTION | 76% | No | No |
| 018 | CYSTOGRAFIN | DIATRIZOATE MEGLUMINE | SOLUTION;URETHRAL | 30% | Yes | No |
| 019 | RENOVIST II | DIATRIZOATE MEGLUMINE; DIATRIZOATE SODIUM | INJECTABLE;INJECTION | 28.5%;29.1% | No | No |
| 020 | RENOVIST | DIATRIZOATE MEGLUMINE; DIATRIZOATE SODIUM | INJECTABLE;INJECTION | 34.3%;35% | No | No |
| 021 | RENO-30 | DIATRIZOATE MEGLUMINE | SOLUTION;URETERAL | 30% | No | No |
| 022 | CYSTOGRAFIN DILUTE | DIATRIZOATE MEGLUMINE | SOLUTION;URETHRAL | 18% | Yes | No |
Orange Book products#
| Application-product | Trade name | Ingredient | Strength | Dosage form / route | TE codes | RLD / RS | Approval date |
|---|---|---|---|---|---|---|---|
| N010040-001 | RENOGRAFIN-76 | DIATRIZOATE MEGLUMINE; DIATRIZOATE SODIUM | 66%;10% | INJECTABLE / INJECTION | RLD, Approved before 1982 | ||
| N010040-006 | RENOGRAFIN-60 | DIATRIZOATE MEGLUMINE; DIATRIZOATE SODIUM | 52%;8% | INJECTABLE / INJECTION | Approved before 1982 | ||
| N010040-012 | RENO-DIP | DIATRIZOATE MEGLUMINE | 30% | INJECTABLE / INJECTION | Approved before 1982 | ||
| N010040-016 | RENO-60 | DIATRIZOATE MEGLUMINE | 60% | INJECTABLE / INJECTION | Approved before 1982 | ||
| N010040-017 | DIATRIZOATE MEGLUMINE | DIATRIZOATE MEGLUMINE | 76% | INJECTABLE / INJECTION | Approved before 1982 | ||
| N010040-018 | CYSTOGRAFIN | DIATRIZOATE MEGLUMINE | 30% | SOLUTION / URETHRAL | RLD, Approved before 1982 | ||
| N010040-019 | RENOVIST II | DIATRIZOATE MEGLUMINE; DIATRIZOATE SODIUM | 28.5%;29.1% | INJECTABLE / INJECTION | Approved before 1982 | ||
| N010040-020 | RENOVIST | DIATRIZOATE MEGLUMINE; DIATRIZOATE SODIUM | 34.3%;35% | INJECTABLE / INJECTION | Approved before 1982 | ||
| N010040-021 | RENO-30 | DIATRIZOATE MEGLUMINE | 30% | SOLUTION / URETERAL | Approved before 1982 | ||
| N010040-022 | CYSTOGRAFIN DILUTE | DIATRIZOATE MEGLUMINE | 18% | SOLUTION / URETHRAL | RLD | 1982-11-09 |
Observed Orange Book product history#
Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
| Captured | Edition | Application-product | Trade name | Strength | Dosage form / route | Product TE source text | RLD / RS | Approval date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|
| 2026-02-19 14:30 UTC | 2026-02 | N010040-001 | RENOGRAFIN-76 | 66%;10% | INJECTABLE / INJECTION | RLD, Approved before 1982 | 011fe1cb6892… | ||
| 2026-02-19 14:30 UTC | 2026-02 | N010040-006 | RENOGRAFIN-60 | 52%;8% | INJECTABLE / INJECTION | Approved before 1982 | 011fe1cb6892… | ||
| 2026-02-19 14:30 UTC | 2026-02 | N010040-012 | RENO-DIP | 30% | INJECTABLE / INJECTION | Approved before 1982 | 011fe1cb6892… | ||
| 2026-02-19 14:30 UTC | 2026-02 | N010040-016 | RENO-60 | 60% | INJECTABLE / INJECTION | Approved before 1982 | 011fe1cb6892… | ||
| 2026-02-19 14:30 UTC | 2026-02 | N010040-017 | DIATRIZOATE MEGLUMINE | 76% | INJECTABLE / INJECTION | Approved before 1982 | 011fe1cb6892… | ||
| 2026-02-19 14:30 UTC | 2026-02 | N010040-018 | CYSTOGRAFIN | 30% | SOLUTION / URETHRAL | RLD, Approved before 1982 | 011fe1cb6892… | ||
| 2026-02-19 14:30 UTC | 2026-02 | N010040-019 | RENOVIST II | 28.5%;29.1% | INJECTABLE / INJECTION | Approved before 1982 | 011fe1cb6892… | ||
| 2026-02-19 14:30 UTC | 2026-02 | N010040-020 | RENOVIST | 34.3%;35% | INJECTABLE / INJECTION | Approved before 1982 | 011fe1cb6892… | ||
| 2026-02-19 14:30 UTC | 2026-02 | N010040-021 | RENO-30 | 30% | SOLUTION / URETERAL | Approved before 1982 | 011fe1cb6892… | ||
| 2026-02-19 14:30 UTC | 2026-02 | N010040-022 | CYSTOGRAFIN DILUTE | 18% | SOLUTION / URETHRAL | RLD | 1982-11-09 | 011fe1cb6892… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N010040-001 | RENOGRAFIN-76 | 66%;10% | INJECTABLE / INJECTION | RLD, Approved before 1982 | 31067a03dcf5… | ||
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N010040-006 | RENOGRAFIN-60 | 52%;8% | INJECTABLE / INJECTION | Approved before 1982 | 31067a03dcf5… | ||
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N010040-012 | RENO-DIP | 30% | INJECTABLE / INJECTION | Approved before 1982 | 31067a03dcf5… | ||
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N010040-016 | RENO-60 | 60% | INJECTABLE / INJECTION | Approved before 1982 | 31067a03dcf5… | ||
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N010040-017 | DIATRIZOATE MEGLUMINE | 76% | INJECTABLE / INJECTION | Approved before 1982 | 31067a03dcf5… | ||
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N010040-018 | CYSTOGRAFIN | 30% | SOLUTION / URETHRAL | RLD, Approved before 1982 | 31067a03dcf5… | ||
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N010040-019 | RENOVIST II | 28.5%;29.1% | INJECTABLE / INJECTION | Approved before 1982 | 31067a03dcf5… | ||
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N010040-020 | RENOVIST | 34.3%;35% | INJECTABLE / INJECTION | Approved before 1982 | 31067a03dcf5… | ||
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N010040-021 | RENO-30 | 30% | SOLUTION / URETERAL | Approved before 1982 | 31067a03dcf5… | ||
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N010040-022 | CYSTOGRAFIN DILUTE | 18% | SOLUTION / URETHRAL | RLD | 1982-11-09 | 31067a03dcf5… | |
| 2025-08-23 18:47 UTC | 2025-08 | N010040-001 | RENOGRAFIN-76 | 66%;10% | INJECTABLE / INJECTION | RLD, Approved before 1982 | 6a471c1ec25d… | ||
| 2025-08-23 18:47 UTC | 2025-08 | N010040-006 | RENOGRAFIN-60 | 52%;8% | INJECTABLE / INJECTION | Approved before 1982 | 6a471c1ec25d… | ||
| 2025-08-23 18:47 UTC | 2025-08 | N010040-012 | RENO-DIP | 30% | INJECTABLE / INJECTION | Approved before 1982 | 6a471c1ec25d… | ||
| 2025-08-23 18:47 UTC | 2025-08 | N010040-016 | RENO-60 | 60% | INJECTABLE / INJECTION | Approved before 1982 | 6a471c1ec25d… | ||
| 2025-08-23 18:47 UTC | 2025-08 | N010040-017 | DIATRIZOATE MEGLUMINE | 76% | INJECTABLE / INJECTION | Approved before 1982 | 6a471c1ec25d… | ||
| 2025-08-23 18:47 UTC | 2025-08 | N010040-018 | CYSTOGRAFIN | 30% | SOLUTION / URETHRAL | RLD, Approved before 1982 | 6a471c1ec25d… | ||
| 2025-08-23 18:47 UTC | 2025-08 | N010040-019 | RENOVIST II | 28.5%;29.1% | INJECTABLE / INJECTION | Approved before 1982 | 6a471c1ec25d… | ||
| 2025-08-23 18:47 UTC | 2025-08 | N010040-020 | RENOVIST | 34.3%;35% | INJECTABLE / INJECTION | Approved before 1982 | 6a471c1ec25d… | ||
| 2025-08-23 18:47 UTC | 2025-08 | N010040-021 | RENO-30 | 30% | SOLUTION / URETERAL | Approved before 1982 | 6a471c1ec25d… | ||
| 2025-08-23 18:47 UTC | 2025-08 | N010040-022 | CYSTOGRAFIN DILUTE | 18% | SOLUTION / URETHRAL | RLD | 1982-11-09 | 6a471c1ec25d… | |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | N010040-001 | RENOGRAFIN-76 | 66%;10% | INJECTABLE / INJECTION | RLD, Approved before 1982 | fd3edfee7708… | ||
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | N010040-006 | RENOGRAFIN-60 | 52%;8% | INJECTABLE / INJECTION | Approved before 1982 | fd3edfee7708… | ||
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | N010040-012 | RENO-DIP | 30% | INJECTABLE / INJECTION | Approved before 1982 | fd3edfee7708… | ||
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | N010040-016 | RENO-60 | 60% | INJECTABLE / INJECTION | Approved before 1982 | fd3edfee7708… | ||
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | N010040-017 | DIATRIZOATE MEGLUMINE | 76% | INJECTABLE / INJECTION | Approved before 1982 | fd3edfee7708… | ||
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | N010040-018 | CYSTOGRAFIN | 30% | SOLUTION / URETHRAL | RLD, Approved before 1982 | fd3edfee7708… | ||
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | N010040-019 | RENOVIST II | 28.5%;29.1% | INJECTABLE / INJECTION | Approved before 1982 | fd3edfee7708… | ||
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | N010040-020 | RENOVIST | 34.3%;35% | INJECTABLE / INJECTION | Approved before 1982 | fd3edfee7708… | ||
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | N010040-021 | RENO-30 | 30% | SOLUTION / URETERAL | Approved before 1982 | fd3edfee7708… | ||
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | N010040-022 | CYSTOGRAFIN DILUTE | 18% | SOLUTION / URETHRAL | RLD | 1982-11-09 | fd3edfee7708… |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Cystografin Dilute | DIATRIZOATE MEGLUMINE | BRACCO DIAGNOSTICS INC | e56882fa-4a30-43b1-bb6b-f7d4a4101c4e | 2025-11-23 | Warnings, Adverse reactions | 010040 NDA010040 0270-1410 |
| Cystografin | DIATRIZOATE MEGLUMINE | BRACCO DIAGNOSTICS INC | 7496d736-9f7d-4136-ad5d-b24c7803c21b | 2025-11-23 | Warnings, Adverse reactions | 010040 NDA010040 0270-0149 |